New England Journal of Medicine · 1984 · 298 citations · 19 references
MedicineOncologyPathologyCardiac TransplantationCellular PathologyNeoplasiaHeart TransplantationHematopoietic NeoplasmsLymphoid NeoplasmsLymphoid Tissue PathologyLymphoid TumorsTransplant PathologyClonal B Cell ProliferationsNeoplastic DiseasePolyclonal B-cell ProliferationPosttransplant Lymphoproliferative DisorderTransplant-associated Malignancy
Whether lymphoproliferative disorders arising in immunosuppressed recipients of organ transplants are primarily neoplastic or hyperplastic in nature is a matter of controversy. Reports of polyclonal B-cell proliferations in these lesions suggest the presence of hyperplasia, but these disorders resemble lymphoma histologically and are clinically aggressive and often rapidly fatal, as expected of a malignant neoplastic disease. We examined tissue specimens from 10 cases of lymphoproliferative disease that occurred in immunosuppressed recipients of cardiac transplants. Specimens from nine of these patients lacked cellular immunoglobulin; however, analysis of DNA extracted from these tissues revealed that each lesion contained large numbers of cells possessing uniform, clonal rearrangements of immunoglobulin-gene DNA. Therefore, when first seen clinically these proliferations contained a notable monoclonal-cell population typical of conventional B-cell lymphomas that are not associated with immunosuppression. We therefore suggest that lymphoproliferative disorders in recipients of cardiac transplants are neoplastic at the earliest stages of detectable disease.
19
Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal Transplantation
Douglas W. Hanto, Glauco Frizzera, David T. Purtilo et al. · New England Journal of Medicine · 1982 · 485 citations
Medicine, Hematology, Pathology +17